Dataset Information


Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling.

ABSTRACT: The transcription factor Kruppel-like factor 2 (KLF2) displays anticarcinogenic activities but the mechanism that underlies this activity is unknown. We show here that KLF2 is markedly downregulated in human breast cancers and that its expression positively correlates with breast cancer patient survival. We show further that KLF2 suppresses tumor development by controlling the transcriptional activity of the vitamin A metabolite retinoic acid (RA). RA regulates gene transcription by activating two types of nuclear receptors: RA receptors (RARs), which inhibit tumor development, and peroxisome proliferator-activated receptor ?/? (PPAR?/?), which promotes tumorigenesis. The partitioning of RA between these receptors is regulated by two carrier proteins: cellular retinoic acid-binding protein 2 (CRABP2), which delivers RA to RARs, and fatty acid-binding protein 5 (FABP5), which shuttles ligands to PPAR?/?. We show that KLF2 induces the expression of CRABP2 and RAR? and inhibits the expression FABP5 and PPAR?/? thereby shifting RA signaling from the pro-carcinogenic FABP5/PPAR?/? to the growth-suppressing CRABP2/RAR path. The data thus reveal that KLF2 suppresses tumor growth by controlling the transcriptional activities of RA.


PROVIDER: S-EPMC4742144 | BioStudies | 2015-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3744553 | BioStudies
2017-01-01 | S-EPMC5333850 | BioStudies
1000-01-01 | S-EPMC3331760 | BioStudies
2016-01-01 | S-EPMC5595534 | BioStudies
1000-01-01 | S-EPMC2396692 | BioStudies
2015-01-01 | S-EPMC4662070 | BioStudies
2018-01-01 | S-EPMC6066298 | BioStudies
1993-01-01 | S-EPMC1134887 | BioStudies
2014-01-01 | S-EPMC4256341 | BioStudies
2007-01-01 | S-EPMC1948722 | BioStudies